Jazz Pharmaceuticals PLC banner

Jazz Pharmaceuticals PLC
NASDAQ:JAZZ

Watchlist Manager
Jazz Pharmaceuticals PLC Logo
Jazz Pharmaceuticals PLC
NASDAQ:JAZZ
Watchlist
Price: 171.12 USD 0.9% Market Closed
Market Cap: $10.4B

Balance Sheet

Balance Sheet Decomposition
Jazz Pharmaceuticals PLC

Balance Sheet
Jazz Pharmaceuticals PLC

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2005 Dec-2006 Dec-2007 Dec-2008 Dec-2009 Dec-2010 Dec-2011 Dec-2012 Dec-2013 Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023 Dec-2024
Assets
Cash & Cash Equivalents
21
79
103
25
16
45
82
387
637
684
989
366
386
216
333
517
511
851
1 506
2 413
Cash
0
0
0
0
0
0
0
0
0
0
0
0
0
216
333
517
511
334
438
949
Cash Equivalents
21
79
103
25
16
45
82
387
637
684
989
366
386
0
0
0
0
517
1 069
1 464
Short-Term Investments
0
0
0
1
0
0
76
0
0
0
0
60
215
609
744
1 616
81
30
120
580
Total Receivables
4
5
5
7
12
22
34
75
125
186
210
234
224
264
356
396
563
743
855
717
Accounts Receivables
4
5
5
7
12
22
34
75
125
186
210
234
224
264
356
396
563
651
706
717
Other Receivables
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
92
149
0
Inventory
3
3
2
4
3
5
4
27
29
30
19
34
43
53
79
95
1 073
714
597
480
Other Current Assets
4
4
5
7
6
3
3
62
74
116
40
54
100
93
118
214
383
268
357
439
Total Current Assets
31
92
116
44
37
74
199
552
865
1 016
1 258
748
968
1 234
1 630
2 840
2 611
2 606
3 435
4 629
PP&E Net
2
2
4
3
1
1
2
7
14
58
86
107
170
200
271
257
343
301
235
227
PP&E Gross
2
2
4
3
1
1
2
7
14
58
86
107
170
200
271
257
343
301
235
227
Accumulated Depreciation
1
1
3
4
5
6
7
8
11
15
24
32
41
50
55
68
85
108
133
162
Intangible Assets
79
69
36
33
30
22
15
870
812
1 437
1 186
3 012
2 979
2 731
2 441
2 195
7 152
5 794
5 418
4 756
Goodwill
39
38
38
38
38
38
38
443
450
703
657
894
948
928
920
958
1 828
1 693
1 753
1 716
Other Long-Term Assets
14
14
13
0
1
0
0
95
97
125
147
39
59
110
277
286
364
441
552
684
Other Assets
39
38
38
38
38
38
38
443
450
703
657
894
948
928
920
958
1 828
1 693
1 753
1 716
Total Assets
165
N/A
215
+30%
208
-3%
117
-44%
107
-9%
136
+27%
254
+87%
1 966
+674%
2 238
+14%
3 339
+49%
3 333
0%
4 800
+44%
5 124
+7%
5 203
+2%
5 539
+6%
6 536
+18%
12 299
+88%
10 835
-12%
11 393
+5%
12 012
+5%
Liabilities
Accounts Payable
5
5
3
6
2
3
5
16
21
25
22
22
24
41
48
27
100
91
103
78
Accrued Liabilities
11
13
29
16
12
13
20
105
120
164
164
193
199
263
267
349
647
803
793
900
Short-Term Debt
0
2
3
4
9
7
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
0
0
0
119
24
16
0
30
6
9
38
36
41
33
33
246
31
31
605
31
Other Current Liabilities
7
10
1
29
12
20
28
41
58
18
3
6
30
8
17
31
30
8
36
29
Total Current Liabilities
23
31
37
173
59
60
53
192
204
217
227
257
294
345
364
654
809
933
1 537
1 039
Long-Term Debt
89
74
75
0
91
25
0
427
544
1 333
1 151
1 994
1 540
1 563
1 574
1 849
6 025
5 699
5 113
6 082
Deferred Income Tax
0
0
0
0
0
0
0
178
168
375
283
557
383
309
224
130
1 301
944
848
677
Minority Interest
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Other Liabilities
1
14
27
24
30
21
8
48
26
43
73
115
193
228
265
243
198
173
159
121
Total Liabilities
113
N/A
119
+5%
139
+17%
198
+42%
180
-9%
105
-42%
61
-42%
845
+1 285%
943
+12%
1 968
+109%
1 734
-12%
2 923
+69%
2 411
-18%
2 446
+1%
2 428
-1%
2 876
+18%
8 333
+190%
7 750
-7%
7 656
-1%
7 919
+3%
Equity
Common Stock
164
264
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Retained Earnings
118
178
316
501
508
475
350
61
19
35
303
529
918
842
1 068
1 160
831
734
879
1 128
Additional Paid In Capital
0
1
371
408
435
505
543
1 151
1 220
1 458
1 563
1 665
1 935
2 114
2 266
2 634
3 535
3 477
3 700
3 914
Other Equity
6
8
13
12
0
0
0
31
56
122
267
317
141
198
223
134
400
1 126
842
948
Total Equity
52
N/A
96
+85%
68
-29%
80
N/A
73
+9%
31
N/A
193
+523%
1 121
+481%
1 296
+16%
1 371
+6%
1 599
+17%
1 877
+17%
2 713
+45%
2 757
+2%
3 111
+13%
3 660
+18%
3 965
+8%
3 086
-22%
3 737
+21%
4 094
+10%
Total Liabilities & Equity
165
N/A
215
+30%
208
-3%
117
-44%
107
-9%
136
+27%
254
+87%
1 966
+674%
2 238
+14%
3 339
+49%
3 333
0%
4 800
+44%
5 124
+7%
5 203
+2%
5 539
+6%
6 536
+18%
12 299
+88%
10 835
-12%
11 393
+5%
12 012
+5%
Shares Outstanding
Common Shares Outstanding
25
25
25
29
31
40
42
58
58
61
61
60
60
58
56
56
62
63
62
61
Preferred Shares Outstanding
11
18
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0